Patents by Inventor Patrick Veiga

Patrick Veiga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200155622
    Abstract: The present invention relates to the use of at least one Lactobacillus bacterium, or a composition comprising thereof or conditioned thereby, for decreasing a population of Bilophila wadsworthia or inhibiting the growth thereof
    Type: Application
    Filed: May 22, 2017
    Publication date: May 21, 2020
    Inventors: Harry SOKOL, Philippe LANGELLA, Jane NATIVIDAD, Patrick VEIGA, Johan VAN HYLCKAMA VLIEG
  • Patent number: 10383921
    Abstract: Disclosed herein are compositions and methods for providing an antioxidant effect to a subject, e.g., modulating or otherwise improving oxidative stress pathways and/or neutralizing or reducing damaging reactive oxygen species (ROS).
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: August 20, 2019
    Assignees: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, COMPAGNIE GERVAIS DANONE
    Inventors: Wendy S. Garrett, Patrick Veiga, Sonia Arora Ballal, Johan van Hylckama Vlieg, Gaëlle Quéré, Peggy Garault
  • Publication number: 20160193303
    Abstract: Disclosed herein are compositions and methods for providing an antioxidant effect to a subject, e.g., modulating or otherwise improving oxidative stress pathways and/or neutralizing or reducing damaging reactive oxygen species (ROS).
    Type: Application
    Filed: August 13, 2014
    Publication date: July 7, 2016
    Inventors: Wendy S. Garrett, Patrick Veiga, Sonia Arora Ballal, Johan van Hylckama Vlieg, Gaëlle Quéré, Peggy Garault
  • Patent number: 8685388
    Abstract: The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific Bifidobacterium bacteria, in particular a fermented dairy product comprising said specific Bifidobacterium bacteria for the prevention, treatment and reduction of gastro-intestinal inflammation, in particular for the prevention and treatment of inflammatory bowel disease (IBD), ulcerative colitis (UC) and/or Crohn's Disease (CD) and for the prevention and treatment of Irritable Bowel Syndrome (IBS).
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: April 1, 2014
    Assignees: Compagnie Gervais Danone, President and Fellows of Harvard College
    Inventors: Patrick Veiga, Isabelle Chambaud, Artem Khlebnikov, Laurie H. Glimcher, Wendy S. Garrett
  • Publication number: 20120308523
    Abstract: The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific Bifidobacterium bacteria, in particular a fermented dairy product comprising said specific Bifidobacterium bacteria for the prevention, treatment and reduction of gastro-intestinal inflammation, in particular for the prevention and treatment of inflammatory bowel disease (IBD), ulcerative colitis (UC) and/or Crohn's Disease (CD) and for the prevention and treatment of Irritable Bowel Syndrome (IBS).
    Type: Application
    Filed: November 2, 2009
    Publication date: December 6, 2012
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, COMPAGNIE GERVAIS DANONE
    Inventors: Patrick Veiga, Isabelle Chambaud, Artem Khlebnikov, Laurie H. Glimcher, Wendy S. Garrett
  • Publication number: 20120128633
    Abstract: The invention relates to compositions comprising Collinsella aerofaciens for use for reducing bloating, in particular in subjects suffering from irritable bowel syndrome.
    Type: Application
    Filed: April 30, 2009
    Publication date: May 24, 2012
    Applicant: CAMPAGNIE GERVAISE DONONE
    Inventors: Patrick Veiga, Raish Oozber, Karine Roy, Stephanie Cools-Portier, Aurore Tessier, Pascale Rondeau, Denis Guyonnet
  • Publication number: 20120128634
    Abstract: The invention relates to compositions comprising Collinsella aerofaciens for use for reducing bloating, in particular in subjects suffering from irritable bowel syndrome.
    Type: Application
    Filed: April 30, 2010
    Publication date: May 24, 2012
    Applicant: CAMPAGNIE GERVAISE DONONE
    Inventors: Patrick Veiga, Raish Oozeer, Karine Roy, Stéphanie Cools-Portier, Aurore Tessier, Pascale Rondeau, Denis Guyonnet, Richéle Deodata Wind